Evidence map›Paper›PMID 38872705›Full record

ArticleCureus2024

The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving Surgery.

Akihiro Nakashima, Hideya Yamazaki, Gen Suzuki, Kei Yamada, Norihiro Aibe, Takuya Kimoto, Koji Masui, Katsuhiko Nakatsukasa, Tetsuya Taguchi, Yasuto Naoi

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Akihiro NakashimaRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Hideya YamazakiRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Gen SuzukiRadiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Kei YamadaRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Norihiro AibeRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Takuya KimotoRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Koji MasuiRadiology, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Katsuhiko NakatsukasaEndocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Tetsuya TaguchiEndocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.
Yasuto NaoiEndocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background This study was aimed at analyzing the impact of postoperative radiotherapy (PORT) after breast-conserving surgery (BCS) on Japanese patients with early-stage breast cancer and exploring the potential of PORT omission. Materials and methods Data from 794 patients with early-stage breast cancer (T1-2, N0-1), who underwent BCS with (n = 310) or without PORT (n = 484) were retrospectively analyzed. Local control (LC) rate and breast cancer-specific survival (BCSS) were compared between the groups that received and did not receive PORT in the whole cohort and low-risk cohort (i.e., the cohort with negative surgical margin, lymph node negativity, and estrogen receptor positivity, excluding young age of 49 or less), and in low-risk subgroup using propensity-score matching. Results PORT was associated with better LC but not BCSS in the total population. In the low-risk cohort, the incidence of local recurrence in patients without and with PORT was 5.3% and 4.8%, respectively, at 10 years (p = 0.591), and 7.8% and 4.8%, respectively, according to propensity-score matching (p = 0.485). Conclusion PORT improved LC in the total population, but not BCSS or overall survival (OS). In the low-risk group analysis (negative surgical margin, lymph node negativity, estrogen receptor positivity, and age 50 years or more), equivalent LC, BCSS, and OS were found including propensity-matched comparison. Therefore, this study showed that the omission of PORT could be a treatment option for low-risk Japanese patients. Further multi-center prospective studies are warranted to validate these findings and reduce the unnecessary burden of PORT for patients and institutions.

Indexed as

breast cancerbreast-conserving surgeryinvasive carcinomaomission of postoperative radiotherapypostoperative radiotherapy

Identifiers

PMID38872705
PMCPMC11168898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.